The UK's largest pharmaceutical company, Rafa, has announced a joint partnership with the British Pharmaceuticals and Drug Administration (FDA) to promote access to medicines for rare diseases in developing countries in the Middle East and Eastern Europe (CEE).
Source: prnewswire.comPublished on 2022-08-01
Related news
- SKT to Lead AI Transformation in Industry and Society with AI Services and Technologies
- TechCabal Daily - The crypto game 🎮
- iOS 15 Impact on Email Marketing
- Accenture Makes Strategic Investment in African Fintech Startup Okra
- Why has Da Nang taken the lead in digital transformation ?
- What new in the Consumer Data Right ?
- Open Mineral And Sherritt Partner To Tackle Arsenic In Preci ...
- Five Things Governments Can Do to Encourage Civic Startups
- Disentangling The Digital Battlefield : How the Internet Has Changed War
- MeitY draft data policy looks to unlock govt data for all
- Futu Accelerates International Expansion as the Company Announces Third Quarter 2021 Unaudited Financial Results
- 21Vianet Wins 5A Green Data Center Ratings and Further Promotes Carbon Reduction
- Presentation to the National Space Council User Advisory Group by Thomas Zurbuchen
- Databricks Launches Lakehouse for Financial Services to Accelerate Data - Driven Innovation Across the Industry
- Observing water - related events to support decision - making